APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Midazolam Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Midazolam Injection Industry Growth and Trends Forecast to 2032

Report ID 17401333012 January 2026103 pages

Choose your research edition.

Industry ResearchMidazolam Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Midazolam Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Midazolam Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Midazolam Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Midazolam Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Midazolam Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Midazolam Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Midazolam Injection include Yichang Humanwell Pharmaceutical, Sandoz, Jiangsu Nhwa Group, Pfizer, Fresenius Kabi, Sun Pharmaceutical, Hikma, Hameln Pharma and Avet Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Midazolam Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Midazolam Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Midazolam Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Midazolam Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Midazolam Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Midazolam Injection Market by Company

Yichang Humanwell Pharmaceutical

Sandoz

Jiangsu Nhwa Group

Pfizer

Fresenius Kabi

Sun Pharmaceutical

Hikma

Hameln Pharma

Avet Pharmaceuticals

Athenex

Akorn

Midazolam Injection Segment by Type

1mg/ml

5mg/ml

Midazolam Injection Segment by Application

Recovery Center

Hospital

Clinics

Midazolam Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Midazolam Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Midazolam Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Midazolam Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Midazolam Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Midazolam Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg/ml Table 2. Major Company of 5mg/ml Table 3. Global Midazolam Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Midazolam Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Midazolam Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Midazolam Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Midazolam Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Midazolam Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Midazolam Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Midazolam Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Midazolam Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Midazolam Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Midazolam Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Midazolam Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Midazolam Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Midazolam Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Midazolam Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Midazolam Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Midazolam Injection Industry Trends Table 25. Midazolam Injection Industry Drivers Table 26. Midazolam Injection Industry Opportunities and Challenges Table 27. Midazolam Injection Industry Restraints Table 28. Global Midazolam Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Midazolam Injection Revenue Market Share by Company (2021-2026) Table 30. Global Midazolam Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Midazolam Injection Sales Share by Company (2021-2026) Table 32. Global Midazolam Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Midazolam Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Midazolam Injection Major Company Production Sites and Headquarters Table 35. Global Midazolam Injection Company, Product Type & Application Table 36. Global Midazolam Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Midazolam Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Midazolam Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Midazolam Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Midazolam Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Midazolam Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Midazolam Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Midazolam Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Midazolam Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Midazolam Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Midazolam Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Midazolam Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Midazolam Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Midazolam Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Midazolam Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Midazolam Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Midazolam Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Midazolam Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Midazolam Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Midazolam Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Midazolam Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Midazolam Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Midazolam Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Midazolam Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Midazolam Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Midazolam Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Midazolam Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Midazolam Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Midazolam Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Yichang Humanwell Pharmaceutical Company Information Table 72. Yichang Humanwell Pharmaceutical Business Overview Table 73. Yichang Humanwell Pharmaceutical Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolio Table 75. Yichang Humanwell Pharmaceutical Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sandoz Midazolam Injection Product Portfolio Table 80. Sandoz Recent Development Table 81. Jiangsu Nhwa Group Company Information Table 82. Jiangsu Nhwa Group Business Overview Table 83. Jiangsu Nhwa Group Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Jiangsu Nhwa Group Midazolam Injection Product Portfolio Table 85. Jiangsu Nhwa Group Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Midazolam Injection Product Portfolio Table 90. Pfizer Recent Development Table 91. Fresenius Kabi Company Information Table 92. Fresenius Kabi Business Overview Table 93. Fresenius Kabi Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Fresenius Kabi Midazolam Injection Product Portfolio Table 95. Fresenius Kabi Recent Development Table 96. Sun Pharmaceutical Company Information Table 97. Sun Pharmaceutical Business Overview Table 98. Sun Pharmaceutical Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sun Pharmaceutical Midazolam Injection Product Portfolio Table 100. Sun Pharmaceutical Recent Development Table 101. Hikma Company Information Table 102. Hikma Business Overview Table 103. Hikma Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hikma Midazolam Injection Product Portfolio Table 105. Hikma Recent Development Table 106. Hameln Pharma Company Information Table 107. Hameln Pharma Business Overview Table 108. Hameln Pharma Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Hameln Pharma Midazolam Injection Product Portfolio Table 110. Hameln Pharma Recent Development Table 111. Avet Pharmaceuticals Company Information Table 112. Avet Pharmaceuticals Business Overview Table 113. Avet Pharmaceuticals Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Avet Pharmaceuticals Midazolam Injection Product Portfolio Table 115. Avet Pharmaceuticals Recent Development Table 116. Athenex Company Information Table 117. Athenex Business Overview Table 118. Athenex Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Athenex Midazolam Injection Product Portfolio Table 120. Athenex Recent Development Table 121. Akorn Company Information Table 122. Akorn Business Overview Table 123. Akorn Midazolam Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Akorn Midazolam Injection Product Portfolio Table 125. Akorn Recent Development Table 126. North America Midazolam Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 128. North America Midazolam Injection Sales Market Share by Country (2021-2026) Table 129. North America Midazolam Injection Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Midazolam Injection Sales Market Share Forecast by Country (2027-2032) Table 131. North America Midazolam Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Midazolam Injection Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Midazolam Injection Market Share by Country (2021-2026) Table 134. North America Midazolam Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Midazolam Injection Market Share Forecast by Country (2027-2032) Table 136. Europe Midazolam Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 138. Europe Midazolam Injection Sales Market Share by Country (2021-2026) Table 139. Europe Midazolam Injection Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Midazolam Injection Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Midazolam Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Midazolam Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Midazolam Injection Market Share by Country (2021-2026) Table 144. Europe Midazolam Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Midazolam Injection Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Midazolam Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Midazolam Injection Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Midazolam Injection Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Midazolam Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Midazolam Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Midazolam Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Midazolam Injection Market Share by Country (2021-2026) Table 154. Asia-Pacific Midazolam Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Midazolam Injection Market Share Forecast by Country (2027-2032) Table 156. Latin America Midazolam Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 158. Latin America Midazolam Injection Sales Market Share by Country (2021-2026) Table 159. Latin America Midazolam Injection Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Midazolam Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Midazolam Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Midazolam Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Midazolam Injection Market Share by Country (2021-2026) Table 164. Latin America Midazolam Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Midazolam Injection Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Midazolam Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Midazolam Injection Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Midazolam Injection Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Midazolam Injection Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Midazolam Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Midazolam Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Midazolam Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Midazolam Injection Market Share by Country (2021-2026) Table 174. Middle East and Africa Midazolam Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Midazolam Injection Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Midazolam Injection Distributors List Table 179. Midazolam Injection Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Midazolam Injection Image Figure 2. Global Midazolam Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Midazolam Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Midazolam Injection Sales (2021-2032) & (K Units) Figure 5. 1mg/ml Image Figure 6. Global 1mg/ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5mg/ml Image Figure 8. Global 5mg/ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Midazolam Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Midazolam Injection Market Share by Type 2025 VS 2032 Figure 11. North America Midazolam Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Midazolam Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Midazolam Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Midazolam Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Midazolam Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Midazolam Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Midazolam Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Midazolam Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Midazolam Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Midazolam Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Midazolam Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Recovery Center Image Figure 24. Global Recovery Center Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Midazolam Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Midazolam Injection Market Share by Application 2025 VS 2032 Figure 31. North America Midazolam Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Midazolam Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Midazolam Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Midazolam Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Midazolam Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Midazolam Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Midazolam Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Midazolam Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Midazolam Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Midazolam Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Midazolam Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Midazolam Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Midazolam Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Midazolam Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Midazolam Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Midazolam Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Midazolam Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Midazolam Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Midazolam Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Midazolam Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Midazolam Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Midazolam Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Midazolam Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Midazolam Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Midazolam Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Midazolam Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Midazolam Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Midazolam Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg/ml
  • 5mg/ml
Applications
  • Recovery Center
  • Hospital
  • Clinics
Companies covered
  • Yichang Humanwell Pharmaceutical
  • Sandoz
  • Jiangsu Nhwa Group
  • Pfizer
  • Fresenius Kabi
  • Sun Pharmaceutical
  • Hikma
  • Hameln Pharma
  • Avet Pharmaceuticals
  • Athenex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Midazolam Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Midazolam Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Midazolam Injection Market by Type
  6. 1.3.1 1mg/ml
  7. 1.3.2 5mg/ml
  8. 1.4 Global Midazolam Injection Market Size by Type
  9. 1.4.1 Global Midazolam Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Midazolam Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Midazolam Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Midazolam Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Midazolam Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Midazolam Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Midazolam Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Midazolam Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Midazolam Injection Industry Trends
  2. 2.2 Midazolam Injection Industry Drivers
  3. 2.3 Midazolam Injection Industry Opportunities and Challenges
  4. 2.4 Midazolam Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Midazolam Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Midazolam Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Midazolam Injection Price (2021-2026)
  4. 3.4 Global Midazolam Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Midazolam Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Midazolam Injection Company, Product Type & Application
  7. 3.7 Global Midazolam Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Midazolam Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Midazolam Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Midazolam Injection Tier 1, Tier 2, and Tier 3
4 Midazolam Injection Regional Status and Outlook
  1. 4.1 Global Midazolam Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Midazolam Injection Historic Market Size by Region
  3. 4.2.1 Global Midazolam Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Midazolam Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Midazolam Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Midazolam Injection Forecasted Market Size by Region
  7. 4.3.1 Global Midazolam Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Midazolam Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Midazolam Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Midazolam Injection by Application
  1. 5.1 Midazolam Injection Market by Application
  2. 5.1.1 Recovery Center
  3. 5.1.2 Hospital
  4. 5.1.3 Clinics
  5. 5.2 Global Midazolam Injection Market Size by Application
  6. 5.2.1 Global Midazolam Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Midazolam Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Midazolam Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Midazolam Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Midazolam Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Midazolam Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Midazolam Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Midazolam Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yichang Humanwell Pharmaceutical
  2. 6.1.1 Yichang Humanwell Pharmaceutical Company Information
  3. 6.1.2 Yichang Humanwell Pharmaceutical Business Overview
  4. 6.1.3 Yichang Humanwell Pharmaceutical Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yichang Humanwell Pharmaceutical Midazolam Injection Product Portfolio
  6. 6.1.5 Yichang Humanwell Pharmaceutical Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Midazolam Injection Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Jiangsu Nhwa Group
  14. 6.3.1 Jiangsu Nhwa Group Company Information
  15. 6.3.2 Jiangsu Nhwa Group Business Overview
  16. 6.3.3 Jiangsu Nhwa Group Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Nhwa Group Midazolam Injection Product Portfolio
  18. 6.3.5 Jiangsu Nhwa Group Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Midazolam Injection Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Midazolam Injection Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Sun Pharmaceutical
  32. 6.6.1 Sun Pharmaceutical Company Information
  33. 6.6.2 Sun Pharmaceutical Business Overview
  34. 6.6.3 Sun Pharmaceutical Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sun Pharmaceutical Midazolam Injection Product Portfolio
  36. 6.6.5 Sun Pharmaceutical Recent Developments
  37. 6.7 Hikma
  38. 6.7.1 Hikma Company Information
  39. 6.7.2 Hikma Business Overview
  40. 6.7.3 Hikma Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hikma Midazolam Injection Product Portfolio
  42. 6.7.5 Hikma Recent Developments
  43. 6.8 Hameln Pharma
  44. 6.8.1 Hameln Pharma Company Information
  45. 6.8.2 Hameln Pharma Business Overview
  46. 6.8.3 Hameln Pharma Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hameln Pharma Midazolam Injection Product Portfolio
  48. 6.8.5 Hameln Pharma Recent Developments
  49. 6.9 Avet Pharmaceuticals
  50. 6.9.1 Avet Pharmaceuticals Company Information
  51. 6.9.2 Avet Pharmaceuticals Business Overview
  52. 6.9.3 Avet Pharmaceuticals Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Avet Pharmaceuticals Midazolam Injection Product Portfolio
  54. 6.9.5 Avet Pharmaceuticals Recent Developments
  55. 6.10 Athenex
  56. 6.10.1 Athenex Company Information
  57. 6.10.2 Athenex Business Overview
  58. 6.10.3 Athenex Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Athenex Midazolam Injection Product Portfolio
  60. 6.10.5 Athenex Recent Developments
  61. 6.11 Akorn
  62. 6.11.1 Akorn Company Information
  63. 6.11.2 Akorn Business Overview
  64. 6.11.3 Akorn Midazolam Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Akorn Midazolam Injection Product Portfolio
  66. 6.11.5 Akorn Recent Developments
7 North America by Country
  1. 7.1 North America Midazolam Injection Sales by Country
  2. 7.1.1 North America Midazolam Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Midazolam Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Midazolam Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Midazolam Injection Market Size by Country
  6. 7.2.1 North America Midazolam Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Midazolam Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Midazolam Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Midazolam Injection Sales by Country
  2. 8.1.1 Europe Midazolam Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Midazolam Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Midazolam Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Midazolam Injection Market Size by Country
  6. 8.2.1 Europe Midazolam Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Midazolam Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Midazolam Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Midazolam Injection Sales by Country
  2. 9.1.1 Asia-Pacific Midazolam Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Midazolam Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Midazolam Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Midazolam Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Midazolam Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Midazolam Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Midazolam Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Midazolam Injection Sales by Country
  2. 10.1.1 South America Midazolam Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Midazolam Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Midazolam Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Midazolam Injection Market Size by Country
  6. 10.2.1 South America Midazolam Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Midazolam Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Midazolam Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Midazolam Injection Sales by Country
  2. 11.1.1 Middle East and Africa Midazolam Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Midazolam Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Midazolam Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Midazolam Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Midazolam Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Midazolam Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Midazolam Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Midazolam Injection Value Chain Analysis
  2. 12.1.1 Midazolam Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Midazolam Injection Production Mode & Process
  7. 12.2 Midazolam Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Midazolam Injection Distributors
  10. 12.2.3 Midazolam Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst